| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |